Current Price Disclosure cycle – 2025 April

Page last updated: 28 March 2025

The 2025 April cycle has a data collection period of 1 April 2024 to 30 September 2024.

Responsible persons must have disclosed brand data to the Price Disclosure Data Administrator (PDDA) by the deadline of 12 November 2024.

The reduction day is 1 April 2025.

Responsible persons should ensure that their authorised representatives keep their details up to date via the Health Products Portal, and sign up to the PBS Newsletter.

Contents

Outcomes of Price Disclosure calculations

The PDDA calculates weighted average disclosed prices (WADPs) to be provided to the Department of Health and Aged Care. The Minister determines WADPs calculated in accordance with the National Health Act 1953 (the Act) and National Health (Pharmaceutical Benefits) Regulations 2017 (the Regulations).

The outcomes reflecting these determinations have been published in a legal determination on the Federal Register of Legislation website.  Price disclosure reductions will apply to brands listed in Schedule 1 of the legal determination. Brands in Schedule 2 of the determination will not take a price disclosure reduction because the percentage difference between their December 2024 PBS approved ex‑manufacturer price (AEMP) and the weighted average disclosed price (WADP) was below 10% or 30% (as applicable). Any new brands of existing pharmaceutical items with a determination in Schedule 1 that listed after 30 September 2024 will also take the reduction on 1 April 2025  under section 99ADHA of the Act.

Please note an agreed process for responsible persons to raise any questions or concerns arising from an outcome mentioned above is set out in the Price Disclosure Dispute Resolution Administrative Process. The deadline to lodge a dispute was 14 January 2025.

A list of pharmaceutical items scheduled for a price disclosure reduction and their weighted average disclosed prices is presented in the table below.

Legal Instrument Drug

Legal Instrument Form

Legal Instrument MoA

Brands of PI designated brands under 99ADHC (Y/N)

Floor Price

Price reduction applied in 2 previous cycles (Y/N)

Average Unadjusted Price Reduction (UPR) exceeds 12.5% over 3 cycles (Y/N)

December 2024 AEMP

April 2025 AEMP

Percentage difference between December 2024 and April 2025 AEMP (%)

UPR threshold (%)

Calculations based on:
OWAPD = all brand data, or
GWAPD = originator brand data removed

Adalimumab

Injection 20 mg in 0.4 mL pre-filled syringe

Injection

N

-

-

-

$309.45

$272.84

11.83%

10%

GWAPD

Adalimumab

Injection 40 mg in 0.4 mL pre-filled pen

Injection

N

-

-

-

$505.95

$444.17

12.21%

10%

GWAPD

Azacitidine

Powder for injection 100 mg

Injection

Y

$40.79

N

Y

$40.79

$25.69

37.02%

30%

OWAPD

Bevacizumab

Solution for I.V. infusion 100 mg in 4 mL

Injection

N

-

-

-

$61.77

$53.82

12.87%

10%

OWAPD

Bevacizumab

Solution for I.V. infusion 400 mg in 16 mL

Injection

N

-

-

-

$247.07

$215.28

12.87%

10%

OWAPD

Bortezomib

Powder for injection 2.5 mg

Injection

N

-

-

-

$28.47

$24.92

12.47%

10%

GWAPD

Bortezomib

Powder for injection 3.5 mg

Injection

N

-

-

-

$39.85

$34.88

12.47%

10%

GWAPD

Bortezomib

Solution for injection 2.5 mg in 1 mL

Injection

N

-

-

-

$28.47

$24.92

12.47%

10%

GWAPD

Bortezomib

Solution for injection 3.5 mg in 1.4 mL

Injection

N

-

-

-

$39.85

$34.88

12.47%

10%

GWAPD

Carvedilol

Tablet 12.5 mg

Oral

Y

$5.05

N

Y

$5.05

$4.00

20.79%

10%

GWAPD

Carvedilol

Tablet 25 mg

Oral

Y

$6.31

N

Y

$6.31

$4.79

24.09%

10%

GWAPD

Carvedilol

Tablet 6.25 mg

Oral

Y

$4.04

N

Y

$4.04

$4.00

0.99%

10%

GWAPD

Cinacalcet

Tablet 30 mg (as hydrochloride)

Oral

N

-

-

-

$23.72

$19.75

16.74%

10%

GWAPD

Cinacalcet

Tablet 60 mg (as hydrochloride)

Oral

N

-

-

-

$47.44

$39.51

16.72%

10%

GWAPD

Cinacalcet

Tablet 90 mg (as hydrochloride)

Oral

N

-

-

-

$71.16

$59.26

16.72%

10%

GWAPD

Clomipramine

Tablet containing clomipramine hydrochloride 25 mg

Oral

Y

$5.52

N

Y

$5.52

$4.65

15.76%

10%

GWAPD

Cyclophosphamide

Powder for injection 2 g (anhydrous)

Injection

N

-

-

-

$37.18

$31.20

16.08%

10%

OWAPD

Dabigatran etexilate

Capsule 110 mg (as mesilate)

Oral

N

-

-

-

$6.19

$5.53

10.66%

10%

OWAPD

Dabigatran etexilate

Capsule 150 mg (as mesilate)

Oral

N

-

-

-

$36.88

$32.94

10.68%

10%

OWAPD

Dasatinib

Tablet 100 mg

Oral

N

-

-

-

$1,197.56

$1,019.07

14.90%

10%

OWAPD

Dasatinib

Tablet 20 mg

Oral

N

-

-

-

$727.08

$618.71

14.90%

10%

OWAPD

Dasatinib

Tablet 50 mg

Oral

N

-

-

-

$1,197.56

$1,019.07

14.90%

10%

OWAPD

Dasatinib

Tablet 70 mg

Oral

N

-

-

-

$1,482.66

$1,261.67

14.90%

10%

OWAPD

Deferasirox

Tablet 180 mg

Oral

N

-

-

-

$60.54

$29.02

52.06%

10%

GWAPD

Deferasirox

Tablet 360 mg

Oral

N

-

-

-

$121.09

$58.04

52.07%

10%

GWAPD

Deferasirox

Tablet 90 mg

Oral

N

-

-

-

$30.27

$14.51

52.06%

10%

GWAPD

Enoxaparin

Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe

Injection

N

-

-

-

$91.60

$71.24

22.23%

10%

GWAPD

Enoxaparin

Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe

Injection

N

-

-

-

$103.62

$80.59

22.23%

10%

GWAPD

Enoxaparin

Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe

Injection

N

-

-

-

$129.53

$100.74

22.23%

10%

GWAPD

Enoxaparin

Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe

Injection

N

-

-

-

$33.58

$26.12

22.22%

10%

GWAPD

Enoxaparin

Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe

Injection

N

-

-

-

$37.53

$29.19

22.22%

10%

GWAPD

Enoxaparin

Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe

Injection

N

-

-

-

$64.97

$50.53

22.23%

10%

GWAPD

Enoxaparin

Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe

Injection

N

-

-

-

$69.08

$53.72

22.24%

10%

GWAPD

Erlotinib

Tablet 100 mg (as hydrochloride)

Oral

N

-

-

-

$460.68

$379.60

17.60%

10%

OWAPD

Erlotinib

Tablet 150 mg (as hydrochloride)

Oral

N

-

-

-

$569.91

$469.61

17.60%

10%

OWAPD

Erlotinib

Tablet 25 mg (as hydrochloride)

Oral

N

-

-

-

$126.93

$104.59

17.60%

10%

OWAPD

Esomeprazole and clarithromycin and amoxicillin

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

Oral

N

-

-

-

$23.65

$20.69

12.52%

10%

OWAPD

Esomeprazole and clarithromycin and amoxicillin

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

Oral

N

-

-

-

$23.65

$20.69

12.52%

10%

OWAPD

Exemestane

Tablet 25 mg

Oral

Y

$42.25

N

Y

$42.25

$35.19

16.71%

10%

GWAPD

Fulvestrant

Injection 250 mg in 5 mL pre-filled syringe

Injection

N

-

-

-

$164.59

$134.60

18.22%

10%

GWAPD

Gabapentin

Tablet 600 mg

Oral

Y

$23.12

N

Y

$23.12

$19.16

17.13%

10%

GWAPD

Ganirelix

Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe

Injection

N

-

-

-

$24.77

$22.10

10.78%

10%

GWAPD

Lamotrigine

Tablet 5 mg

Oral

Y

$5.88

N

Y

$5.88

$4.79

18.54%

10%

GWAPD

Lansoprazole

Capsule 30 mg

Oral

Y

$4.48

N

Y

$4.48

$4.00

10.71%

10%

GWAPD

Lansoprazole

Tablet 30 mg (orally disintegrating)

Oral

Y

$4.48

N

Y

$4.48

$4.00

10.71%

10%

GWAPD

Lenalidomide

Capsule 10 mg

Oral

N

-

-

-

$669.88

$548.44

18.13%

10%

OWAPD

Lenalidomide

Capsule 15 mg

Oral

N

-

-

-

$806.80

$660.53

18.13%

10%

OWAPD

Lenalidomide

Capsule 25 mg

Oral

N

-

-

-

$1,055.57

$864.20

18.13%

10%

OWAPD

Lenalidomide

Capsule 5 mg

Oral

N

-

-

-

$511.34

$418.64

18.13%

10%

OWAPD

Levodopa with carbidopa and entacapone

Tablet 100 mg-25 mg (as monohydrate)-200 mg

Oral

N

-

-

-

$67.44

$56.96

15.54%

10%

GWAPD

Levodopa with carbidopa and entacapone

Tablet 125 mg-31.25 mg (as monohydrate)-200 mg

Oral

N

-

-

-

$70.00

$59.12

15.54%

10%

GWAPD

Levodopa with carbidopa and entacapone

Tablet 150 mg-37.5 mg (as monohydrate)-200 mg

Oral

N

-

-

-

$73.82

$62.35

15.54%

10%

GWAPD

Levodopa with carbidopa and entacapone

Tablet 200 mg-50 mg (as monohydrate)-200 mg

Oral

N

-

-

-

$79.69

$67.31

15.54%

10%

GWAPD

Levodopa with carbidopa and entacapone

Tablet 50 mg-12.5 mg (as monohydrate)-200 mg

Oral

N

-

-

-

$61.06

$51.57

15.54%

10%

GWAPD

Levodopa with carbidopa and entacapone

Tablet 75 mg-18.75 mg (as monohydrate)-200 mg

Oral

N

-

-

-

$63.86

$53.94

15.53%

10%

GWAPD

Levothyroxine

Tablet containing 100 micrograms anhydrous levothyroxine sodium

Oral

N

-

-

-

$9.73

$8.32

14.49%

10%

GWAPD

Levothyroxine

Tablet containing 125 micrograms anhydrous levothyroxine sodium

Oral

N

-

-

-

$12.49

$10.68

14.49%

10%

GWAPD

Levothyroxine

Tablet containing 200 micrograms anhydrous levothyroxine sodium

Oral

N

-

-

-

$11.41

$9.76

14.46%

10%

GWAPD

Levothyroxine

Tablet containing 50 micrograms anhydrous levothyroxine sodium

Oral

N

-

-

-

$9.39

$8.03

14.48%

10%

GWAPD

Levothyroxine

Tablet containing 75 micrograms anhydrous levothyroxine sodium

Oral

N

-

-

-

$9.55

$8.17

14.45%

10%

GWAPD

Lurasidone

Tablet containing lurasidone hydrochloride 40 mg

Oral

N

-

-

-

$18.99

$14.52

23.54%

10%

GWAPD

Lurasidone

Tablet containing lurasidone hydrochloride 80 mg

Oral

N

-

-

-

$37.97

$29.04

23.52%

10%

GWAPD

Mefenamic acid

Capsule 250 mg

Oral

N

-

-

-

$5.79

$4.56

21.24%

10%

GWAPD

Morphine

Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL

Injection

N

-

-

-

$4.42

$3.85

12.90%

10%

OWAPD

Morphine

Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL

Injection

N

-

-

-

$6.77

$5.89

13.00%

10%

OWAPD

Naltrexone

Tablet containing naltrexone hydrochloride 50 mg

Oral

N

-

-

-

$85.54

$76.68

10.36%

10%

OWAPD

Nebivolol

Tablet 1.25 mg (as hydrochloride)

Oral

N

-

-

-

$9.78

$8.59

12.17%

10%

GWAPD

Nebivolol

Tablet 10 mg (as hydrochloride)

Oral

N

-

-

-

$27.60

$24.24

12.17%

10%

GWAPD

Nebivolol

Tablet 5 mg (as hydrochloride)

Oral

N

-

-

-

$24.42

$21.44

12.20%

10%

GWAPD

Perindopril

Tablet containing perindopril arginine 10 mg

Oral

Y

$4.07

N

Y

$4.07

$4.00

1.72%

10%

GWAPD

Perindopril

Tablet containing perindopril erbumine 8 mg

Oral

Y

$4.07

N

Y

$4.07

$4.00

1.72%

10%

GWAPD

Sildenafil

Tablet 20 mg (as citrate)

Oral

Y

$131.30

N

Y

$131.30

$95.81

27.03%

10%

GWAPD

Sitagliptin

Tablet 100 mg

Oral

N

-

-

-

$22.93

$19.33

15.70%

10%

OWAPD

Sitagliptin

Tablet 25 mg

Oral

N

-

-

-

$22.93

$19.33

15.70%

10%

OWAPD

Sitagliptin

Tablet 50 mg

Oral

N

-

-

-

$22.93

$19.33

15.70%

10%

OWAPD

Sunitinib

Capsule 12.5 mg

Oral

N

-

-

-

$581.73

$513.55

11.72%

10%

OWAPD

Sunitinib

Capsule 25 mg

Oral

N

-

-

-

$1,170.80

$1,033.58

11.72%

10%

OWAPD

Sunitinib

Capsule 37.5 mg

Oral

N

-

-

-

$1,754.71

$1,549.06

11.72%

10%

OWAPD

Sunitinib

Capsule 50 mg

Oral

N

-

-

-

$2,370.50

$2,092.68

11.72%

10%

OWAPD

Tacrolimus

Capsule 0.5 mg

Oral

Y

$63.14

N

Y

$63.14

$51.48

18.47%

10%

GWAPD

Tacrolimus

Capsule 1 mg

Oral

Y

$126.29

N

Y

$126.29

$102.96

18.47%

10%

GWAPD

Tacrolimus

Capsule 1 mg (once daily prolonged release)

Oral

Y

$75.78

N

Y

$75.78

$61.78

18.47%

10%

GWAPD

Tacrolimus

Capsule 2 mg

Oral

Y

$287.81

N

Y

$287.81

$234.65

18.47%

10%

GWAPD

Tacrolimus

Capsule 5 mg

Oral

Y

$315.57

N

Y

$315.57

$257.28

18.47%

10%

GWAPD

Tobramycin

Solution for inhalation 300 mg in 5 mL

Inhalation

Y

$416.76

N

Y

$416.76

$322.41

22.64%

10%

GWAPD

Trastuzumab

Powder for I.V. infusion 420 mg

Injection

Y

$346.50

N

Y

$346.50

$298.41

13.88%

10%

OWAPD

Trastuzumab

Powder for I.V. infusion 60 mg

Injection

Y

$58.09

N

Y

$58.09

$50.03

13.88%

10%

OWAPD

Vancomycin

Capsule 125 mg (125,000 I.U.) (as hydrochloride)

Oral

N

-

-

-

$50.69

$44.16

12.88%

10%

GWAPD

Vancomycin

Capsule 250 mg (250,000 I.U.) (as hydrochloride)

Oral

N

-

-

-

$101.36

$88.30

12.88%

10%

GWAPD

Varenicline

Box containing 11 tablets 0.5 mg and 42 tablets 1 mg

Oral

N

-

-

-

$51.66

$45.35

12.21%

10%

OWAPD

Varenicline

Tablet 1 mg

Oral

N

-

-

-

$60.90

$53.46

12.22%

10%

OWAPD

Flow-on price disclosure reductions

A list of brands of pharmaceutical items that will be subject to an automatic flow-on price disclosure reduction under section 99ADHB of the National Health Act 1953 on 1 April 2025 is available in the Pricing-Combination-Flow-on-Price-Reductions-FED-1-Apr-2025 (Excel 12KB). Sponsors are able to apply for Ministerial discretion for these reductions to be reduced or not apply. For more information see Ministerial Discretion.

Confirmed prices of brands scheduled for a price disclosure reduction

The Confirmed Prices Report outlines the approved ex‑manufacturer prices for brands scheduled to take a price disclosure reduction. The reports for the 2025 April cycle can be downloaded below.

Brand price reductions and savings to patients

The Brand Price Reductions and Savings to Patients Report outlines the price disclosure reductions per brand and potential savings to non-concessional patients from 1 April 2025. This information is made available to assist patients understand how much they may save on their PBS medicines.

The report does not include any brands of medicines that have other price changes, or brands that are new to the PBS on the reduction day.

The brand price reductions report for the 2025 April cycle can be downloaded below.